This helps your provider see whether symptoms like dizziness, sweating, anxiety, or shakiness match blood sugar changes, reduced food intake, cannabis effects, or medication side effects
There is extensive data supporting the use of disease-modifying medications and biologics in treating inflammatory arthritis
Food and Drug Administration FDA Approves New Medication for Chronic Weight Management (Zepbound / tirzepatide)
Weight loss differs accordingly: Wegovy 2.4 mg: around 15% weight loss over 68 weeks
Affecting estimated 35 million people globally, NASH is the most common chronic liver condition in Western populations, and with patient numbers growing rapidly, the market for NASH therapy is projected to rise to $27.2 B in 2029